Press release
Heart Failure Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight
DelveInsight's "Heart Failure Market Insights, Epidemiology, and Market Forecast - 2032" report delivers an in-depth understanding of the Heart Failure, historical and forecasted epidemiology as well as the Heart Failure market trends in the United States, EU4 (Germany, Spain, Italy, France) and the United Kingdom, and Japan.Discover which therapies are expected to grab the Heart Failure Market Share @ Heart Failure Market Outlook- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Heart Failure Market Research Report
• In May 2025, AstraZeneca announced a study will include an optional pre-screening period to facilitate sites' identification of potentially eligible participants to enter the full screening assessments. Participants will not be required to visit the site and no informed consent is required for the optional pre-screening period. The pre-screening assessments do not replace the full screening tests at Visit 1.
• In May 2025, Boehringer Ingelheim conducted a study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure.
• In May 2025, Bristol-Myers Squibb organized a study is to evaluate the safety, tolerability, and exposure-response (E-R) of BMS-986435/MYK-224 in participants with symptomatic Heart Failure with Preserved Ejection Fraction (HFpEF).
• The increase in Heart Failure Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Heart Failure market is anticipated to witness growth at a considerable CAGR.
• The leading Heart Failure Companies working in the market include Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, and many others.
• Promising Heart Failure Pipeline Therapies in the various stages of development include CXL-1020, Strata 1 CXL-1020, Ularitide, JTT-861 Capsules, JARDIANCE®, Allogeneic Mesenchymal Bone Marrow Cells (aMBMC), Bisoprolol, Empagliflozin, Lixivaptan, and others.
Stay ahead in the Heart Failure Therapeutics Market with DelveInsight's Strategic Report @ Heart Failure Market Outlook- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Epidemiology Insights
The epidemiology section of Heart Failure offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Heart Failure Epidemiology trends @ Heart Failure Prevalence- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Drugs Market
The Heart Failure Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Heart Failure signaling in Heart Failure are likely to uncover new therapeutic targets and further expand treatment options for patients.
Heart Failure Treatment Market Landscape
The Heart Failure treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Heart Failure has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To know more about Heart Failure treatment guidelines, visit @ Heart Failure Treatment Market Landscape- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Market Outlook
The report's outlook on the Heart Failure market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Heart Failure therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Heart Failure drug and late-stage pipeline therapy.
Heart Failure Drugs Uptake
The drug chapter of the Heart Failure report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Heart Failure.
Major Heart Failure Companies
Several Heart Failure Companies working in the market include Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, and many others
Learn more about the FDA-approved drugs for Heart Failure @ Drugs for Heart Failure Treatment- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Heart Failure Market Research Report
• Coverage- 7MM
• Study Period- 2019-2032
• Heart Failure Companies- Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, and many others
• Heart Failure Pipeline Therapies- CXL-1020, Strata 1 CXL-1020, Ularitide, JTT-861 Capsules, JARDIANCE®, Allogeneic Mesenchymal Bone Marrow Cells (aMBMC), Bisoprolol, Empagliflozin, Lixivaptan, and others.
• Heart Failure Market Dynamics: Heart Failure Market Drivers and Barriers
• Heart Failure Market Access and Reimbursement, Unmet Needs, KOL's Views, and Analyst's Views
Discover more about Heart Failure Drugs in development @ Heart Failure Clinical Trials Assessment- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Heart Failure
3. Competitive Intelligence Analysis for Heart Failure
4. Heart Failure: Market Overview at a Glance
5. Heart Failure: Disease Background and Overview
6. Patient Journey
7. Heart Failure Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Heart Failure Unmet Needs
10. Key Endpoints of Heart Failure Treatment
11. Heart Failure Marketed Products
12. Heart Failure Emerging Therapies
13. Heart Failure: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Heart Failure
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
List of Top Selling Market Research Reports in 2025
Radiation retinopathy market- https://www.delveinsight.com/sample-request/radiation-retinopathy-market
Immune checkpoints activators market- https://www.delveinsight.com/report-store/immune-checkpoint-inhibitors-market
Cystic fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Palmoplantar pustulosis market- https://www.delveinsight.com/report-store/palmoplantar-pustulosis-market
Smoking cessation market- https://www.delveinsight.com/report-store/smoking-cessation-and-nicotine-addiction-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Tay-Sachs market- https://www.delveinsight.com/report-store/tay-sachs-disease-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market
Open angle glaucoma market- https://www.delveinsight.com/report-store/glaucoma-market
Acute myeloid leukemia market- https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-market
Asperger syndrome market- https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Bone growth stimulators market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Cardiogenic shock market- https://www.delveinsight.com/report-store/cardiogenic-shock-market
Pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
Pediatric brain tumor market- https://www.delveinsight.com/report-store/pediatric-brain-tumors-market
Pelizaeus-merzbacher disease market- https://www.delveinsight.com/report-store/pelizaeus-merzbacher-disease-market
Peritoneal carcinomatosis market- https://www.delveinsight.com/report-store/peritoneal-carcinomatosis-pc-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Failure Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight here
News-ID: 4053211 • Views: …
More Releases from DelveInsight Business Research LLP

Genital Warts Pipeline Insights Report 2025 | DelveInsight
DelveInsight's, "Genital Warts Pipeline Insight 2025" report provides comprehensive insights about 30+ companies and 30+ pipeline drugs in Genital Warts pipeline landscape. It covers the Genital Warts pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight and stay ahead…

Traumatic Brain Injury Pipeline Drugs Report 2025 | DelveInsight
DelveInsight's "Traumatic Brain Injury Pipeline Insight 2025" report provides comprehensive insights about 20+ companies and 22+ pipeline drugs in Tthe raumatic Brain Injury pipeline landscape. It covers the Traumatic Brain Injury pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Traumatic Brain Injury pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore…

Bone Metastasis Pipeline Assessment Report 2025 | DelveInsight
DelveInsight's, "Bone Metastases Pipeline Insight, 2025," report provides comprehensive insights about 10+ companies and 10+ pipeline drugs in Bone Metastases pipeline landscape. It covers the Bone Metastasis pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Bone Metastasis pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space.
Explore the comprehensive insights by DelveInsight…

Acquired Immunodeficiency Syndrome Treatment Market Size Report 2032 | DelveInsi …
DelveInsight's "Acquired Immunodeficiency Syndrome Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Acquired Immunodeficiency Syndrome, historical and forecasted epidemiology as well as the Acquired Immunodeficiency Syndrome market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.
To Know in detail about the Acquired Immunodeficiency Syndrome market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Acquired Immunodeficiency Syndrome Market…
More Releases for Heart
Heart Healthy Foods and Supplements vs Heart Conditions
Heart conditions remain a major health concern worldwide, but the good news is that specific heart healthy foods and supplements can significantly improve cardiovascular health.
Scientific research has demonstrated that certain foods, nutrients and supplements support heart function, reduce inflammation, and lower the risk of heart disease.
Top Heart Healthy Foods
Fatty Fish - Salmon, mackerel, and sardines are rich in omega-3 fatty acids, which help lower blood pressure and reduce inflammation. A…
Centrifugal Heart Pumps Market | Abbott Laboratories, Abiomed, Berlin Heart, Car …
The global centrifugal heart pumps market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the centrifugal heart pumps market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
HEART PUMP DEVICES Market 2020 | SWOT Analysis By Top Players Abbott Laboratorie …
A detailed study on HEART PUMP DEVICES Market formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…